Biblio Discovery — Demo Discovery Service

4 hasil untuk "Brian Soper"

Menampilkan 1–4 · 0,78 detik · RSS

  1. Artikel Jurnal

    Cytokine release syndrome and cancer immunotherapies – historical challenges and promising futures

    Deep Shah; Brian Soper; Lindsay Shopland

    Frontiers in Immunology, Vol. 14 · 2023 · Inggris · DOAJ Scopus

    Cancer is the leading cause of death worldwide. Cancer immunotherapy involves reinvigorating the patient’s own immune system to fight against cancer. While novel approaches like Chimeric Antigen Receptor (CAR) T cells, bispecific T cell engagers, and immune checkpoint inhibitors have shown…

  2. Artikel Jurnal

    Innovations, challenges, and minimal information for standardization of humanized mice

    Renata Stripecke; Christian Münz; Jan Jacob Schuringa dkk.

    EMBO Molecular Medicine, Vol. 12 No. 7 · 2020 · Inggris · DOAJ Scopus

    Abstract Mice xenotransplanted with human cells and/or expressing human gene products (also known as “humanized mice”) recapitulate the human evolutionary specialization and diversity of genotypic and phenotypic traits. These models can provide a relevant in vivo context for understanding of…

  3. Artikel Jurnal Teks lengkap

    Long-Term Human Immune Reconstitution, T-Cell Development, and Immune Reactivity in Mice Lacking the Murine Major Histocompatibility Complex: Validation with Cellular and Gene Expression Profiles

    Milita Darguzyte; Philipp Antczak; Daniel Bachurski dkk.

    Cells, Vol. 13 No. 20 · 2024 · Inggris · DOAJ Scopus

    Background: Humanized mice transplanted with CD34+ hematopoietic cells (HPCs) are broadly used to study human immune responses and infections in vivo and for testing therapies pre-clinically. However, until now, it was not clear whether interactions between the mouse major histocompatibility…

  4. Artikel Jurnal

    Impact of antibody Fc engineering on translational pharmacology, and safety: insights from industry case studies

    Frank R. Brennan; J. Ryan Polli; Jean Sathish dkk.

    mAbs, Vol. 17 No. 1 · 2025 · Inggris · DOAJ Scopus

    Therapeutic monoclonal antibodies (mAbs) are often designed to not only bind targets via their antigen-binding domains (Fabs) but to also engage with cell surface receptors, FcγRs and FcRn, through their Fc regions, which may result in a variety of functional outcomes, including antibody- dependent…